Provided herein are compounds, methods, and compositions for determining whether a patient has a neurological
disease or condition, comprising detecting the presence or cumulative
mass thereof of a detectable
target protein in a tissue or sample of the patient, such as the presence or cumulative
mass thereof of
amyloid beta
protein or phosphorylated
tau protein. The detection may comprise contacting the
target protein with a compound described herein.